英文摘要 |
Depression is a common problem for cancer patients. The purposes of this study were (a) to examine the prevalence of depression in Taiwanese cancer inpatients, and (b) to identify medical and demographic variables on prediction of depression. A total of 96 Taiwanese cancer inpatients were recruited in this study. Four instruments were used to collect data: the Demographic Data Form, the Karnofsky Performance Scale, the Pain Assessment Form, and the Mini-International Neuropsychiatric Interview (M.I.N.I.) Schedule. Definition of depression in this study included the psychiatric diagnoses of major depressive disorder, dysthymic disorder, and adjustment disorders with depressed mood or mixed emotional features. The prevalence of depression in this study is 33.3%. Results of univariate logistic regression indicated that depression was related to physical functional status, perceived treatment effect, educational level, and family income. Conditional forward method of multivariate logistic regression revealed that the best subset to predict the depression included functional status, family income, and perceived treatment effect. Using the above three variables, the precision was 77% for predicting the occurrence of depression. The likelihood of being diagnosed as depression was found to increase among subjects with poor functional status, lower family income, and perception of treatment ineffectiveness. For the sub-sample with pain, the best predicting variables for depression were perceived treatment effect, pain pattern, and functional status, with the overall correct rate of 88%. The results of this study confirm that the prevalence of depression in cancer inpatients is high. Poor functional status, perception of treatment ineffectiveness, lower educational level, lower family income, and consistent pain pattern are risk factors of depression. The results indicate that clinical evaluation of risk factors of depression in cancer inpatient is necessary. Nurses should offer more physical and psychosocial support for high-risk patients. |